Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02894112 · ClinicalTrials.gov registry record · NA

Effects of Fluid Milk in Attenuating Hyperglycemia and Hypertriglyceridemia After Meal

A NA study, sponsored by University of Texas at Austin.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT02894112 is a NA study that has completed, run by University of Texas at Austin. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02894112, a NA study, has completed, sponsored by University of Texas at Austin.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

Epidemiological studies indicate that risk of type 2 diabetes is lower when milk is consumed in the regular diet. Milk products are unique in that they produce high insulin response despite their low glycemic index. The general aim of the proposed study is to determine the effect of fluid milk on attenuating the postprandial surge in plasma glucose and triglyceride after meals and its associated physiological mechanisms. The investigators hypothesize that the consumption of one or two servings of non-fat milk added to a standard oral glucose tolerance test (OGTT) solution or the high fat tolerance test meal will attenuate postprandial hyperglycemia and triglyceridemia. The investigators hypothesize that the postulated improvement in postprandial metabolic response due to the consumption of fluid milk will be associated with increased postprandial insulin secretion as well as insulin-mediated endothelial vasodilation and whole-limb perfusion.

Interventions

  • DIETARY_SUPPLEMENT non-fat milk
  • DIETARY_SUPPLEMENT carbohydrate control beverage
  • DIETARY_SUPPLEMENT caloric control beverage

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2013-04
Est. Completion 2015-12
Phase NA

Sponsor

University of Texas at Austin

257 total trials

What the Registry Record Tells You About NCT02894112

The ClinicalTrials.gov registry entry for NCT02894112 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which non-fat milk is the first listed.

NCT02894112 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02894112 about?

NCT02894112 is a clinical study titled "Effects of Fluid Milk in Attenuating Hyperglycemia and Hypertriglyceridemia After Meal". Epidemiological studies indicate that risk of type 2 diabetes is lower when milk is consumed in the regular diet. Milk products are unique in that they produce high insulin response despite their low glycemic index. The general aim of the proposed study is to determine the effect of fluid milk on at...

What is the current status of trial NCT02894112?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2013-04. Estimated completion is 2015-12.

What interventions are being tested in trial NCT02894112?

The interventions under investigation include: non-fat milk (DIETARY_SUPPLEMENT), carbohydrate control beverage (DIETARY_SUPPLEMENT), caloric control beverage (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02894112?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.